Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
Public ClinicalTrials.gov record NCT05421533. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global Prospective observationAl Study of Real-worlD managemEnt of patieNts With atrIal fibrillAtion at High Risk of Stroke (GARDENIA)
Study identification
- NCT ID
- NCT05421533
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Anthos Therapeutics, Inc.
- Industry
- Enrollment
- 705 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 13, 2022
- Primary completion
- Sep 29, 2024
- Completion
- Sep 29, 2024
- Last update posted
- Dec 2, 2024
2022 – 2024
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anthos Investigate Site | Fullerton | California | 92831 | — |
| Anthos Investigate Site | Boca Raton | Florida | 33486 | — |
| Anthos Investigative Site | Homestead | Florida | 33032 | — |
| Anthos Investigate Site | Atlanta | Georgia | 30342 | — |
| Anthos Investigate Site | Marietta | Georgia | 30062 | — |
| Anthos Investigative Site | Lanham | Maryland | 20706 | — |
| Anthos Investigate Site | Detroit | Michigan | 48202 | — |
| Anthos Investigate Site | Cary | North Carolina | 27518 | — |
| Anthos Investigate Site | Tomball | Texas | 77375 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05421533, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05421533 live on ClinicalTrials.gov.